Literature DB >> 11082503

Effects of neuroactive substances on the morphine-induced respiratory depression; an in vitro study.

K Takita1, E Herlenius, Y Yamamoto, S G Lindahl.   

Abstract

Effects of different neuroactive substances on morphine-induced respiratory depression were studied in medullary respiration-related structures using in vitro brainstem-spinal cord preparation from 1 to 4-day-old rats. Application of morphine (10 microM) reduced respiratory rhythm (fR) as measured by C4 ventral root activity. The depressant effects of morphine were reversed by acetylcholine (10 microM), substance P (50 nM), thyrotropin releasing hormone (TRH) (100 nM) and forskolin (10 microM). The adenosine receptor antagonist, theophylline (100 microM), the dopamine receptors antagonist, haloperidol (10 microM), the cyclooxygenase inhibitor, indomethacin (10 microM) and the phospholipase A(2) inhibitor, quinacrine (10 microM) had no effect on morphine-induced respiratory depression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082503     DOI: 10.1016/s0006-8993(00)02921-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats.

Authors:  James D Boghosian; Anita Luethy; Joseph F Cotten
Journal:  J Pharmacol Exp Ther       Date:  2018-04-19       Impact factor: 4.030

Review 2.  Are thyrotropin-releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid-induced respiratory depression?

Authors:  Marieke Hyke Algera; Joseph F Cotten; Monique van Velzen; Marieke Niesters; Martijn Boon; Daniel S Shoham; Kaye E Dandrea; Rutger van der Schrier; Albert Dahan
Journal:  Pharmacol Res Perspect       Date:  2022-06

3.  Excitatory and inhibitory effects of opioid agonists on respiratory motor output produced by isolated brainstems from adult turtles (Trachemys).

Authors:  Stephen M Johnson; Christina M Moris; Michelle E Bartman; Liana M Wiegel
Journal:  Respir Physiol Neurobiol       Date:  2009-10-13       Impact factor: 1.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.